Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine

Transplantation

Volumn 90, Issue 12, 2010, Pages 1336-1343

  Sahara, Hisashi ^a,b   Shimizu, Akira ^a   Setoyama, Kentaro ^a   Oku, Manei ^a   Okumi, Masayoshi ^a   Nishimura, Hiroaki ^a   Oriyanhan, Wunimenghe ^a   Tasaki, Masayuki ^a   Scalea, Joseph ^a   Wada, Hiromi ^b   Bando, Toru ^b   Date, Hiroshi ^b   Yamada, Kazuhiko ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Carbon monoxide; CLAWN miniature swine; Ischemia reperfusion injury; Lung transplantation

Indexed keywords

CARBON MONOXIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; TACROLIMUS;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL MEDIATED LYMPHOLYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MEGADOSE; FLOW CYTOMETRY; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOCOMPATIBILITY COMPLEX; HISTOPATHOLOGY; HLA MATCHING; HLA TYPING; IMMUNOHISTOCHEMISTRY; INBRED STRAIN; LOW DRUG DOSE; LUNG GRAFT REJECTION; LUNG PERFUSION; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MINIPIG; MIXED LYMPHOCYTE REACTION; NONHUMAN; PERIOPERATIVE PERIOD; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME;

ADMINISTRATION, INHALATION; ANIMALS; CARBON MONOXIDE; CELL SURVIVAL; COMPLEMENT SYSTEM PROTEINS; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INBREEDING; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISOANTIBODIES; LUNG TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; PERIOPERATIVE PERIOD; SWINE; SWINE, MINIATURE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650850232     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ff8730     Document Type: Article

References (40)

1. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54.
2. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007; 26: 782.
3. Serrick C, Giaid A, Reis A, et al. Prolonged ischemia is associated with more pronounced rejection in the lung allograft. Ann Thorac Surg 1997; 63: 202.
4. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041.
5. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006; 10: 650.
6. Gunther L, Berberat PO, Haga M, et al. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 2002; 51: 994.
7. Song R, Kubo M, Morse D, et al. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003; 163: 231.
8. Nakao A, Faleo G, Nalesnik MA, et al. Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function. Am J Physiol Renal Physiol 2009; 297: F19.
9. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183.
10. Chauveau C, Bouchet D, Roussel JC, et al. Gene transfer of heme oxygenase- 1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2: 581.
11. Sandouka A, Fuller BJ, Mann BE, et al. Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int 2006; 69: 239.
12. Motterlini R, Clark JE, Foresti R, et al. Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities. Circ Res 2002; 90: E17.
13. Nakao A, Toyokawa H, Abe M, et al. Heart allograft protection with low-dose carbon monoxide inhalation: Effects on inflammatory mediators and alloreactive T-cell responses. Transplantation 2006; 81: 220.
14. Wang H, Lee SS, Gao W, et al. Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 2005; 54: 1400.
15. Sahara H, Shimizu A, Setoyama K, et al. Carbon monoxide reduces pulmonary ischemia-reperfusion injury in miniature swine. J Thorac Cardiovasc Surg 2010; 139: 1594.
16. Nakanishi Y, Ogawa K, Yanagita K, et al. Body measurement and some characteristics of inbred Clawn miniature pigs. Jpn J Swine Sci 1991; 28: 211.
17. Sato M, Keshavjee S, Liu M. Translational research: Animal models of obliterative bronchiolitis after lung transplantation. Am J Transplant 2009; 9: 1981.
18. Kalb TH, Chuang MT, Marom Z, et al. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991; 4: 320.
19. Houser SL, McMorrow IM, LeGuern C, et al. Histomorphometric comparison of cardiac allograft vasculopathy in miniature swine. J Heart Lung Transplant 2004; 23: 50.
20. Ando A, Kawata H, Shigenari A, et al. Genetic polymorphism of the swine major histocompatibility complex (SLA) class I genes, SLA-1, -2 and -3. Immunogenetics 2003; 55: 583.
21. Ando A, Ota M, Sada M, et al. Rapid assignment of the swine major histocompatibility complex (SLA) class I and II genotypes in Clawn miniature swine using PCR-SSP and PCR-RFLP methods. Xenotransplantation 2005; 12: 121.
22. Shoji T, Sahara H, Muniappan A, et al. AnMHCclass II disparity raises the threshold for tolerance induction in pulmonary allografts in miniature swine. Transplant Proc 2006; 38: 3268.
23. Oku M, Okumi M, Sahara H, et al. Maintenance of Treg population and prolongation of allograft survival by hepatocyte growth factor in MHC-inbred CLAWN miniature swine. Supplement to Transplantation, 2008; 86: 8.
24. Matzinger P. Thedangermodel: Arenewedsenseofself. Science 2002;296:301.
25. Land WG. The role of postischemic reperfusion injury and other nonantigen- dependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505.
26. Martins PN, Chandraker A, Tullius SG. Modifying graft immunogenicity and immune response prior to transplantation: Potential clinical applications of donor and graft treatment. Transpl Int 2006; 19: 351.
27. van der Woude FJ. Graft immunogenicity revisited: Relevance of tissue-specific immunity, brain death and donor pretreatment. Nephron 2002; 91: 181.
28. Martins PN, Reutzel-Selke A, Jurisch A, et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006; 82: 938.
29. Crapo JD, Barry BE, Gehr P, et al. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 125: 740.
30. Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172: 4744.
31. Song R, Mahidhara RS, Zhou Z, et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172: 1220.
32. Lee SS, Gao W, Mazzola S, et al. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J 2007; 21: 3450.
33. Oku M, Okumi M, Sahara H, et al. Porcine CFSE mixed lymphocyte reaction and PKH-26 cell-mediated lympholysis assays. Transpl Immunol 2008; 20: 78.
34. Allan JS, Wain JC, Schwarze ML, et al. Modeling chronic lung allograft rejection in miniature swine. Transplantation 2002; 73: 447.
35. Sahara H, Shoji T, Ng CY, et al. The role of indirect recognition ofMHC class I and II allopeptides in a fully mismatched miniature swine model of lung transplantation. Transplant Proc 2006; 38: 3256.
36. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229.
37. Shimizu A, Yamada K, Sachs DH, et al. Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int 2002; 61: 1867.
38. Shimizu A, Yamada K, Sachs DH, et al. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol. Kidney Int 2000; 58: 2546.
39. Utsugi R, Barth RN, Lee RS, et al. Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully MHC-mismatched kidney allografts in miniature swine. Transplantation 2001; 71: 1368.
40. Wong BS, Yamada K, Okumi M, et al. Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase geneknockout miniature swine in patients on transplantation waiting lists. Transplantation 2006; 82: 314.